Global Poliomyelitis Vaccine Market Research Report 2020

Global Poliomyelitis Vaccine Market Research Report 2020

Table of Contents
1 Poliomyelitis Vaccine Market Overview
1.1 Product Overview and Scope of Poliomyelitis Vaccine
1.2 Poliomyelitis Vaccine Segment by Type
1.2.1 Global Poliomyelitis Vaccine Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Poliomyelitis Vaccine ?
1.2.3 Poliomyelitis Vaccine ?
1.2.4 Poliomyelitis Vaccine ?
1.2.5 Oral Poliomyelitis Vaccine
1.3 Poliomyelitis Vaccine Segment by Application
1.3.1 Poliomyelitis Vaccine Sales Comparison by Application: 2020 VS 2026
1.3.2 VAPP
1.3.3 VDPV
1.4 Global Poliomyelitis Vaccine Market Size Estimates and Forecasts
1.4.1 Global Poliomyelitis Vaccine Revenue 2015-2026
1.4.2 Global Poliomyelitis Vaccine Sales 2015-2026
1.4.3 Poliomyelitis Vaccine Market Size by Region: 2020 Versus 2026
2 Global Poliomyelitis Vaccine Market Competition by Manufacturers
2.1 Global Poliomyelitis Vaccine Sales Market Share by Manufacturers (2015-2020)
2.2 Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2015-2020)
2.3 Global Poliomyelitis Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Poliomyelitis Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Poliomyelitis Vaccine Market Competitive Situation and Trends
2.5.1 Poliomyelitis Vaccine Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Poliomyelitis Vaccine Players (Opinion Leaders)
3 Poliomyelitis Vaccine Retrospective Market Scenario by Region
3.1 Global Poliomyelitis Vaccine Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Poliomyelitis Vaccine Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Poliomyelitis Vaccine Market Facts & Figures by Country
3.3.1 North America Poliomyelitis Vaccine Sales by Country
3.3.2 North America Poliomyelitis Vaccine Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Poliomyelitis Vaccine Market Facts & Figures by Country
3.4.1 Europe Poliomyelitis Vaccine Sales by Country
3.4.2 Europe Poliomyelitis Vaccine Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Poliomyelitis Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Poliomyelitis Vaccine Sales by Region
3.5.2 Asia Pacific Poliomyelitis Vaccine Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Poliomyelitis Vaccine Market Facts & Figures by Country
3.6.1 Latin America Poliomyelitis Vaccine Sales by Country
3.6.2 Latin America Poliomyelitis Vaccine Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Poliomyelitis Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Poliomyelitis Vaccine Sales by Country
3.7.2 Middle East and Africa Poliomyelitis Vaccine Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Poliomyelitis Vaccine Historic Market Analysis by Type
4.1 Global Poliomyelitis Vaccine Sales Market Share by Type (2015-2020)
4.2 Global Poliomyelitis Vaccine Revenue Market Share by Type (2015-2020)
4.3 Global Poliomyelitis Vaccine Price Market Share by Type (2015-2020)
4.4 Global Poliomyelitis Vaccine Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Poliomyelitis Vaccine Historic Market Analysis by Application
5.1 Global Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
5.2 Global Poliomyelitis Vaccine Revenue Market Share by Application (2015-2020)
5.3 Global Poliomyelitis Vaccine Price by Application (2015-2020)
6 Company Profiles and Key Figures in Poliomyelitis Vaccine Business
6.1 GSK
6.1.1 Corporation Information
6.1.2 GSK Description, Business Overview and Total Revenue
6.1.3 GSK Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.1.4 GSK Products Offered
6.1.5 GSK Recent Development
6.2 Sanofi-Pasteur
6.2.1 Sanofi-Pasteur Poliomyelitis Vaccine Production Sites and Area Served
6.2.2 Sanofi-Pasteur Description, Business Overview and Total Revenue
6.2.3 Sanofi-Pasteur Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Sanofi-Pasteur Products Offered
6.2.5 Sanofi-Pasteur Recent Development
6.3 Merck
6.3.1 Merck Poliomyelitis Vaccine Production Sites and Area Served
6.3.2 Merck Description, Business Overview and Total Revenue
6.3.3 Merck Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Merck Products Offered
6.3.5 Merck Recent Development
6.4 Crucell
6.4.1 Crucell Poliomyelitis Vaccine Production Sites and Area Served
6.4.2 Crucell Description, Business Overview and Total Revenue
6.4.3 Crucell Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Crucell Products Offered
6.4.5 Crucell Recent Development
6.5 China National Biotech Group
6.5.1 China National Biotech Group Poliomyelitis Vaccine Production Sites and Area Served
6.5.2 China National Biotech Group Description, Business Overview and Total Revenue
6.5.3 China National Biotech Group Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.5.4 China National Biotech Group Products Offered
6.5.5 China National Biotech Group Recent Development
6.6 Eli Lilly
6.6.1 Eli Lilly Poliomyelitis Vaccine Production Sites and Area Served
6.6.2 Eli Lilly Description, Business Overview and Total Revenue
6.6.3 Eli Lilly Poliomyelitis Vaccine Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Eli Lilly Products Offered
6.6.5 Eli Lilly Recent Development
7 Poliomyelitis Vaccine Manufacturing Cost Analysis
7.1 Poliomyelitis Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Poliomyelitis Vaccine
7.4 Poliomyelitis Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Poliomyelitis Vaccine Distributors List
8.3 Poliomyelitis Vaccine Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Poliomyelitis Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Poliomyelitis Vaccine by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Poliomyelitis Vaccine by Type (2021-2026)
10.2 Poliomyelitis Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Poliomyelitis Vaccine by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Poliomyelitis Vaccine by Application (2021-2026)
10.3 Poliomyelitis Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Poliomyelitis Vaccine by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Poliomyelitis Vaccine by Region (2021-2026)
10.4 North America Poliomyelitis Vaccine Estimates and Projections (2021-2026)
10.5 Europe Poliomyelitis Vaccine Estimates and Projections (2021-2026)
10.6 Asia Pacific Poliomyelitis Vaccine Estimates and Projections (2021-2026)
10.7 Latin America Poliomyelitis Vaccine Estimates and Projections (2021-2026)
10.8 Middle East and Africa Poliomyelitis Vaccine Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Poliomyelitis Vaccine Sales (K Units) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Poliomyelitis Vaccine Sales (K Units) Comparison by Application: 2020 VS 2026
Table 3. Global Poliomyelitis Vaccine Market Size by Type (K Units) (US$ Million) (2020 VS 2026)
Table 4. Global Key Poliomyelitis Vaccine Manufacturers Covered in This Study
Table 5. Global Poliomyelitis Vaccine Sales (K Units) by Manufacturers (2015-2020)
Table 6. Global Poliomyelitis Vaccine Sales Share by Manufacturers (2015-2020)
Table 7. Global Poliomyelitis Vaccine Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Poliomyelitis Vaccine Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Poliomyelitis Vaccine Average Price (USD/Unit) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Poliomyelitis Vaccine Sales Sites and Area Served
Table 11. Manufacturers Poliomyelitis Vaccine Product Types
Table 12. Global Poliomyelitis Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Poliomyelitis Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Poliomyelitis Vaccine as of 2019)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Poliomyelitis Vaccine Players
Table 16. Global Poliomyelitis Vaccine Sales (K Units) by Region (2015-2020)
Table 17. Global Poliomyelitis Vaccine Sales Market Share by Region (2015-2020)
Table 18. Global Poliomyelitis Vaccine Revenue (Million US$) by Region (2015-2020)
Table 19. Global Poliomyelitis Vaccine Revenue Market Share by Region (2015-2020)
Table 20. North America Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units)
Table 21. North America Poliomyelitis Vaccine Sales Market Share by Country (2015-2020)
Table 22. North America Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020)
Table 24. Europe Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units)
Table 25. Europe Poliomyelitis Vaccine Sales Market Share by Country (2015-2020)
Table 26. Europe Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Poliomyelitis Vaccine Sales by Region (2015-2020) (K Units)
Table 29. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Poliomyelitis Vaccine Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Poliomyelitis Vaccine Revenue Market Share by Region (2015-2020)
Table 32. Latin America Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units)
Table 33. Latin America Poliomyelitis Vaccine Sales Market Share by Country (2015-2020)
Table 34. Latin America Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Poliomyelitis Vaccine Sales by Country (2015-2020) (K Units)
Table 37. Middle East and Africa Poliomyelitis Vaccine Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Poliomyelitis Vaccine Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Poliomyelitis Vaccine Revenue Market Share by Country (2015-2020)
Table 40. Global Poliomyelitis Vaccine Sales (K Units) by Type (2015-2020)
Table 41. Global Poliomyelitis Vaccine Sales Share by Type (2015-2020)
Table 42. Global Poliomyelitis Vaccine Revenue (Million US$) by Type (2015-2020)
Table 43. Global Poliomyelitis Vaccine Revenue Share by Type (2015-2020)
Table 44. Global Poliomyelitis Vaccine Price (USD/Unit) by Type (2015-2020)
Table 45. Global Poliomyelitis Vaccine Sales (K Units) by Application (2015-2020)
Table 46. Global Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
Table 47. Global Poliomyelitis Vaccine Sales Growth Rate by Application (2015-2020)
Table 48. GSK Poliomyelitis Vaccine Corporation Information
Table 49. GSK Description and Business Overview
Table 50. GSK Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 51. GSK Main Product
Table 52. GSK Recent Development
Table 53. Sanofi-Pasteur Poliomyelitis Vaccine Corporation Information
Table 54. Sanofi-Pasteur Corporation Information
Table 55. Sanofi-Pasteur Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi-Pasteur Main Product
Table 57. Sanofi-Pasteur Recent Development
Table 58. Merck Poliomyelitis Vaccine Corporation Information
Table 59. Merck Corporation Information
Table 60. Merck Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 61. Merck Main Product
Table 62. Merck Recent Development
Table 63. Crucell Poliomyelitis Vaccine Corporation Information
Table 64. Crucell Corporation Information
Table 65. Crucell Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 66. Crucell Main Product
Table 67. Crucell Recent Development
Table 68. China National Biotech Group Poliomyelitis Vaccine Corporation Information
Table 69. China National Biotech Group Corporation Information
Table 70. China National Biotech Group Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 71. China National Biotech Group Main Product
Table 72. China National Biotech Group Recent Development
Table 73. Eli Lilly Poliomyelitis Vaccine Corporation Information
Table 74. Eli Lilly Corporation Information
Table 75. Eli Lilly Poliomyelitis Vaccine Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 76. Eli Lilly Main Product
Table 77. Eli Lilly Recent Development
Table 78. Sales Base and Market Concentration Rate of Raw Material
Table 79. Key Suppliers of Raw Materials
Table 80. Poliomyelitis Vaccine Distributors List
Table 81. Poliomyelitis Vaccine Customers List
Table 82. Market Key Trends
Table 83. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 84. Key Challenges
Table 85. Global Poliomyelitis Vaccine Sales (K Units) Forecast by Type (2021-2026)
Table 86. Global Poliomyelitis Vaccine Sales Market Share Forecast by Type (2021-2026)
Table 87. Global Poliomyelitis Vaccine Revenue (Million US$) Forecast by Type (2021-2026)
Table 88. Global Poliomyelitis Vaccine Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 89. Global Poliomyelitis Vaccine Sales (K Units) Forecast by Application (2021-2026)
Table 90. Global Poliomyelitis Vaccine Revenue (Million US$) Forecast by Application (2021-2026)
Table 91. Global Poliomyelitis Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 92. Global Poliomyelitis Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 93. Global Poliomyelitis Vaccine Revenue Forecast by Region (2021-2026) (US$ Million)
Table 94. Global Poliomyelitis Vaccine Revenue Market Share Forecast by Region (2021-2026)
Table 95. Research Programs/Design for This Report
Table 96. Key Data Information from Secondary Sources
Table 97. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Poliomyelitis Vaccine
Figure 2. Global Poliomyelitis Vaccine Sales Market Share by Type: 2020 VS 2026
Figure 3. Poliomyelitis Vaccine ? Product Picture
Figure 4. Poliomyelitis Vaccine ? Product Picture
Figure 5. Poliomyelitis Vaccine ? Product Picture
Figure 6. Oral Poliomyelitis Vaccine Product Picture
Figure 7. Global Poliomyelitis Vaccine Consumption Market Share by Application: 2020 VS 2026
Figure 8. VAPP
Figure 9. VDPV
Figure 10. Global Poliomyelitis Vaccine Market Size 2015-2026 (US$ Million)
Figure 11. Global Poliomyelitis Vaccine Sales Capacity (K Units) (2015-2026)
Figure 12. Global Poliomyelitis Vaccine Market Size Market Share by Region: 2020 Versus 2026
Figure 13. Poliomyelitis Vaccine Sales Share by Manufacturers in 2020
Figure 14. Global Poliomyelitis Vaccine Revenue Share by Manufacturers in 2019
Figure 15. The Global 5 and 10 Largest Players: Market Share by Poliomyelitis Vaccine Revenue in 2019
Figure 16. Poliomyelitis Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 17. Global Poliomyelitis Vaccine Sales Market Share by Region (2015-2020)
Figure 18. Global Poliomyelitis Vaccine Sales Market Share by Region in 2019
Figure 19. Global Poliomyelitis Vaccine Revenue Market Share by Region (2015-2020)
Figure 20. Global Poliomyelitis Vaccine Revenue Market Share by Region in 2019
Figure 21. North America Poliomyelitis Vaccine Sales Market Share by Country in 2019
Figure 22. North America Poliomyelitis Vaccine Revenue Market Share by Country in 2019
Figure 23. U.S. Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 24. U.S. Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 25. Canada Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 26. Canada Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 27. Europe Poliomyelitis Vaccine Sales Market Share by Country in 2019
Figure 28. Europe Poliomyelitis Vaccine Revenue Market Share by Country in 2019
Figure 29. Germany Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 30. Germany Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. France Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 32. France Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. U.K. Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 34. U.K. Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 35. Italy Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 36. Italy Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. Russia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 38. Russia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Asia Pacific Poliomyelitis Vaccine Sales Market Share by Region in 2019
Figure 40. Asia Pacific Poliomyelitis Vaccine Revenue Market Share by Region in 2019
Figure 41. China Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 42. China Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Japan Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 44. Japan Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. South Korea Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 46. South Korea Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 47. India Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 48. India Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Australia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 50. Australia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. Taiwan Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 52. Taiwan Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Indonesia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 54. Indonesia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Thailand Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 56. Thailand Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Malaysia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 58. Malaysia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Philippines Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 60. Philippines Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Vietnam Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 62. Vietnam Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Latin America Poliomyelitis Vaccine Sales Market Share by Country in 2019
Figure 64. Latin America Poliomyelitis Vaccine Revenue Market Share by Country in 2019
Figure 65. Mexico Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 66. Mexico Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Brazil Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 68. Brazil Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Argentina Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 70. Argentina Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Middle East and Africa Poliomyelitis Vaccine Sales Market Share by Country in 2019
Figure 72. Middle East and Africa Poliomyelitis Vaccine Revenue Market Share by Country in 2019
Figure 73. Turkey Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 74. Turkey Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Saudi Arabia Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 76. Saudi Arabia Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. U.A.E Poliomyelitis Vaccine Sales Growth Rate (2015-2020) (K Units)
Figure 78. U.A.E Poliomyelitis Vaccine Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Sales Market Share of Poliomyelitis Vaccine by Type (2015-2020)
Figure 80. Sales Market Share of Poliomyelitis Vaccine by Type in 2019
Figure 81. Revenue Share of Poliomyelitis Vaccine by Type (2015-2020)
Figure 82. Revenue Market Share of Poliomyelitis Vaccine by Type in 2019
Figure 83. Global Poliomyelitis Vaccine Sales Growth by Type (2015-2020) (K Units)
Figure 84. Global Poliomyelitis Vaccine Sales Market Share by Application (2015-2020)
Figure 85. Global Poliomyelitis Vaccine Sales Market Share by Application in 2019
Figure 86. Global Revenue Share of Poliomyelitis Vaccine by Application (2015-2020)
Figure 87. Global Revenue Share of Poliomyelitis Vaccine by Application in 2020
Figure 88. GSK Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Sanofi-Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Crucell Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. China National Biotech Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Price Trend of Key Raw Materials
Figure 95. Manufacturing Cost Structure of Poliomyelitis Vaccine
Figure 96. Manufacturing Process Analysis of Poliomyelitis Vaccine
Figure 97. Poliomyelitis Vaccine Industrial Chain Analysis
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. North America Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 102. North America Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Poliomyelitis Vaccine Sales (K Units) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Poliomyelitis Vaccine Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87

The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......

Global Esomeprazole Magnesium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74

The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......

Global Combination Therapy Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......

Global Axitinib Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68

The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......

Global Lyme Disease Vaccine Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70

The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......

Global Transdermal Absorption Patch Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......

Global Ketoprofen Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......

Global Methyl Salicylate Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82

The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......

Global Diclofenac Patches Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs